Real-world effectiveness of single-dose tafenoquine for P. vivax relapse prevention confirmed in retrospective observational study in Brazil 05 Mar 2024
The Lancet Global Health publishes groundbreaking results from the Tafenoquine Roll-out STudy (TRuST) in the Brazilian Amazon 14 Feb 2024
Brazil becomes the first malaria-endemic country to register single-dose tafenoquine for children with relapsing malaria 21 Aug 2023
WHO call for public consultation on preferred product characteristics (PPCs) on tests for risk of P. vivax relapse 10 Aug 2023
Brazil becomes the first malaria-endemic country to adopt single-dose tafenoquine and STANDARD G6PD Test for the treatment of relapsing Plasmodium vivax malaria 06 Jun 2023
MMV’s film on real-world tafenoquine study wins advocacy award at the 7th annual ISNTD festival 28 Mar 2023
Regional initiatives and evidence-generation efforts to eliminate P. vivax malaria in Latin America 05 Dec 2022
Start of ARCTIC, a feasibility study of a new Plasmodium vivax malaria treatment protocol in Thailand 22 Jul 2022
Highlights from the Partnership for Vivax Elimination (PAVE) Greater Mekong Subregion (GMS) Country Coordinator Experience Exchange 30 Apr 2022